The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances
Open accessAbstract
Metformin is a widely used drug in today's prescriptions by physicians due to its specific effects in treating and curing type II diabetes. Diabetes is a common disease that may occur throughout human life, and can increase the likelihood of the occurrence of various types of cancer, such as colon, rectum, pancreas and liver cancers, compared to non-diabetic patients. Metformin inhibits mTOR activity by activating ATM (ataxia telangiectasia mutated) and LKB1 (liver kinase B1) and then adenosine monophosphate-activated kinase (AMPK), and thus prevents protein synthesis and cell growth. Metformin can activate p53 by activating AMPK and thereby ultimately stop the cell cycle. Given the potential of metformin in the treatment of cancer, it can be used in radiotherapy, chemotherapy and to improve the response to treatment in androgen derivatives (ADT), and also, according to available evidence, metformin can also be used to prevent various types of cancers. Generally, metformin can: 1) reduce the incidence of cancers, 2) reduce the mortality from cancers, 3) increase the response to treatment in cancer cells when using radiotherapy and chemotherapy, 4) optimize tumor movement and reduce the malignancy, 5) reduce the likelihood of relapse, and 6) reduce the damaging effects of ADT. Therefore, this drug can be used as a complementary therapeutic agent for cancer treatment and prevention. In this review, we have summarized the data from various experimental and clinical studies and highlight the possible potential effects of metformin on cancer therapeutic responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
Metformin: from mechanisms of action to therapies
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105
Metformin: historical overview
Bailey, C. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4318-z · Cited by 1,055
Mechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner
Kalender, A., Selvaraj, A., Kim, S. Y., Gulati, P., Brûlé, S., Viollet, B., Kemp, B. E., Bardeesy, N., Dennis, P., Schlager, J. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.014 · Cited by 889
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 1×
“Furthermore, according to the results of research by Jiralespnog et al on diabetic (n=155) and non-diabetic (n=2,374) patients with breast cancer, pathologic complete remission (pCR) of patients taking metformin along with chemotherapy was higher compared to patients who did not receive metformin.(99) Other related st…”
ResultAMPK signalling in health and disease
Carling, D. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.01.005 · Cited by 797
Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
Polivka, J., & Janku, F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.004 · Cited by 765
Biological response of cancer cells to radiation treatment
Baskar, R., Dai, J., Wenlong, N., Yeo, R., & Yeoh, K.-W. (2014) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2014.00024 · Cited by 638
Pasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G. E., Filicori, M., & Morselli-Labate, A. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6738 · Cited by 635
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Li, D., Yeung, S. J., Hassan, M. M., Konopleva, M., & Abbruzzese, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.013 · Cited by 584
Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
Noto, H., Goto, A., Tsujimoto, T., & Noda, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033411 · Cited by 566
Alimova, I. N., Liu, B., Fan, Z., Edgerton, S. M., Dillon, T., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7933 · Cited by 523
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes
Landman, G. W. D., Kleefstra, N., van Hateren, K. J. J., Groenier, K. H., Gans, R. O. B., & Bilo, H. J. G. (2010) · Diabetes Care · doi:10.2337/dc09-1380 · Cited by 502
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Bodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2010) · Diabetes Care · doi:10.2337/dc09-1791 · Cited by 466
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
Coyle, C., Cafferty, F. H., Vale, C., & Langley, R. E. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw410 · Cited by 452
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3471 · Cited by 450
Understanding the benefit of metformin use in cancer treatment
Dowling, R. J., Goodwin, P. J., & Stambolic, V. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-33 · Cited by 409
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Kovalenko, I. G., Poroshina, T. E., Semenchenko, A. V., Provinciali, M., et al. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.007 · Cited by 402
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Huang, X., Wullschleger, S., Shpiro, N., McGuire, V. A., Sakamoto, K., Woods, Y. L., Mcburnie, W., Fleming, S., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20080557 · Cited by 396
Lee, M.-S., Hsu, C.-C., Wahlqvist, M. L., Tsai, H.-N., Chang, Y.-H., & Huang, Y.-C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-20 · Cited by 380
Jonker, J. W., & Schinkel, A. H. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053298 · Cited by 372
Higurashi, T., Hosono, K., Takahashi, H., Komiya, Y., Umezawa, S., Sakai, E., Uchiyama, T., Taniguchi, L., Hata, Y., Uchiyama, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00565-3 · Cited by 331
Metformin in cancer prevention and therapy.
Kasznicki, J., Śliwińska, A., & Drzewoski, J. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.01 · Cited by 316
Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
Zannella, V. E., Dal Pra, A., Muaddi, H., McKee, T. D., Stapleton, S., Sykes, J., Glicksman, R., Chaib, S., Zamiara, P., Milosevic, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1787 · Cited by 314
Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
Hosono, K., Endo, H., Takahashi, H., Sugiyama, M., Sakai, E., Uchiyama, T., Suzuki, K., Iida, H., Sakamoto, Y., Yoneda, K., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0186 · Cited by 311
Metformin: Multi-faceted protection against cancer
Del Barco, S., Vazquez-Martin, A., Cufí, S., Oliveras-Ferraros, C., Bosch-Barrera, J., Joven, J., Martin-Castillo, B., & Menendez, J. A. (2011) · Oncotarget · doi:10.18632/oncotarget.387 · Cited by 302
Zakikhani, M., Dowling, R. J. O., Sonenberg, N., & Pollak, M. N. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0081 · Cited by 294
Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Flomenberg, N., Birbe, R., Witkiewicz, A. K., Howell, A., Pavlides, S., Tsirigos, A., Ertel, A., Pestell, R. G., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.23.18151 · Cited by 292
Metformin and cancer: new applications for an old drug
Kourelis, T. V., & Siegel, R. D. (2012) · Medical Oncology · doi:10.1007/s12032-011-9846-7 · Cited by 289
Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
Song, C. W., Lee, H., Dings, R. P. M., Williams, B., Powers, J., Santos, T. D., Choi, B.-H., & Park, H. J. (2012) · Scientific Reports · doi:10.1038/srep00362 · Cited by 280
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Soranna, D., Scotti, L., Zambon, A., Bosetti, C., Grassi, G., Catapano, A., La Vecchia, C., Mancia, G., & Corrao, G. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0462 · Cited by 274
Storozhuk, Y., Hopmans, S. N., Sanli, T., Barron, C., Tsiani, E., Cutz, J.-C., Pond, G., Wright, J., Singh, G., & Tsakiridis, T. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.187 · Cited by 273
Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes
Margel, D., Urbach, D. R., Lipscombe, L. L., Bell, C. M., Kulkarni, G., Austin, P. C., & Fleshner, N. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.7043 · Cited by 271
Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives
Ruiter, R., Visser, L. E., van Herk-Sukel, M. P. P., Coebergh, J.-W. W., Haak, H. R., Geelhoed-Duijvestijn, P. H., Straus, S. M. J. M., Herings, R. M. C., & Stricker, B. H. C. (2012) · Diabetes Care · doi:10.2337/dc11-0857 · Cited by 232
Dykens, J. A., Jamieson, J., Marroquin, L., Nadanaciva, S., Billis, P. A., & Will, Y. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.08.013 · Cited by 220
Vazquez-Martin, A., Oliveras-Ferraros, C., Cufí, S., Del Barco, S., Martin-Castillo, B., & Menendez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13131 · Cited by 205
Sulphonylureas and cancer: a case-control study
Monami, M., Lamanna, C., Balzi, D., Marchionni, N., & Mannucci, E. (2009) · Acta Diabetologica · doi:10.1007/s00592-008-0083-2 · Cited by 194
The Role of Metformin in the Management of NAFLD
Mazza, A., Fruci, B., Garinis, G. A., Giuliano, S., Malaguarnera, R., & Belfiore, A. (2012) · Experimental Diabetes Research · doi:10.1155/2012/716404 · Cited by 184
Spratt, D. E., Zhang, C., Zumsteg, Z. S., Pei, X., Zhang, Z., & Zelefsky, M. J. (2013) · European Urology · doi:10.1016/j.eururo.2012.12.004 · Cited by 180
for the ADOPT Study Group and the RECORD Steering Committee, Home, P. D., Kahn, S. E., Jones, N. P., Noronha, D., Beck-Nielsen, H., & Viberti, G. (2010) · Diabetologia · doi:10.1007/s00125-010-1804-y · Cited by 177
Bowker, S. L., Yasui, Y., Veugelers, P., & Johnson, J. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1750-8 · Cited by 165
Saito, S., Furuno, A., Sakurai, J., Sakamoto, A., Park, H.-R., Shin-ya, K., Tsuruo, T., & Tomida, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2689 · Cited by 160
Garrett, C. R., Hassabo, H. M., Bhadkamkar, N. A., Wen, S., Baladandayuthapani, V., Kee, B. K., Eng, C., & Hassan, M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.71 · Cited by 154
Guigas, B., Détaille, D., Chauvin, C., Batandier, C., Oliveira, F. D., Fontaine, E. M., & Leverve, X. M. (2004) · Biochemical Journal · doi:10.1042/bj20040885 · Cited by 153
Scotland, S., Saland, E., Skuli, N., de Toni, F., Boutzen, H., Micklow, E., Sénégas, I., Peyraud, R., Peyriga, L., Théodoro, F., et al. (2013) · Leukemia · doi:10.1038/leu.2013.107 · Cited by 151
Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics
Wright, S. H. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.021 · Cited by 127
Haugrud, A. B., Zhuang, Y., Coppock, J. D., & Miskimins, W. K. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3128-y · Cited by 121
Metformin use and improved response to therapy in esophageal adenocarcinoma
Skinner, H. D., McCurdy, M. R., Echeverria, A. E., Lin, S. H., Welsh, J. W., O’Reilly, M. S., Hofstetter, W. L., Ajani, J. A., Komaki, R. R., Cox, J. D., et al. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.718096 · Cited by 113
Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Monami, M., Colombi, C., Balzi, D., Dicembrini, I., Giannini, S., Melani, C., Vitale, V., Romano, D., Barchielli, A., Marchionni, N., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1287 · Cited by 111
Metformin in polycystic ovary syndrome
Diamanti‐Kandarakis, E., Economou, F., Palimeri, S., & Christakou, C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05679.x · Cited by 109
Metformin and Prostate Cancer: a New Role for an Old Drug
Whitburn, J., Edwards, C. M., & Sooriakumaran, P. (2017) · Current Urology Reports · doi:10.1007/s11934-017-0693-8 · Cited by 99
Metformin and Cancer: Mounting Evidence Against an Association
Suissa, S., & Azoulay, L. (2014) · Diabetes Care · doi:10.2337/dc14-0500 · Cited by 93
Baur, D. M., Klotsche, J., Hamnvik, O. R., Sievers, C., Pieper, L., Wïttchen, H., Stalla, G. K., Schmid, R. M., Kales, S. N., & Mantzoros, C. S. (2010) · Metabolism · doi:10.1016/j.metabol.2010.09.012 · Cited by 91
A Cohort Study of Metformin Exposure and Survival in Patients with Stage I–III Colorectal Cancer
Spillane, S., Bennett, K., Sharp, L., & Barron, T. I. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0347 · Cited by 90
Effects of metformin on head and neck cancer: A systematic review
Rêgo, D. F., Pavan, L. M. C., Elias, S. T., Canto, G. D. L., & Guerra, E. N. S. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.01.007 · Cited by 89
Ooi, G. T., Tseng, L. Y., Tran, M. Q., & Rechler, M. M. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.12.1283442 · Cited by 87
Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients
Bo, S., Ciccone, G., Rosato, R., Villois, P., Appendino, G., Ghigo, E., & Grassi, G. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01480.x · Cited by 86
Oral Hypoglycaemic Agents An Update
Asmal, A. C., & Marble, A. (1984) · Drugs · doi:10.2165/00003495-198428010-00004 · Cited by 83
Cancer incidence among patients treated with antidiabetic pharmacotherapy
Oliveria, S. A., Koro, C. E., Yood, M. U., & Sowell, M. O. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2007.11.002 · Cited by 78
A pilot ‘window of opportunity’ neoadjuvant study of metformin in localised prostate cancer
Joshua, A. M., Zannella, V. E., Downes, M. R., Bowes, B., Hersey, K. M., Koritzinsky, M., Schwab, M. G., Hofmann, U., Evans, A., van der Kwast, T., et al. (2014) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2014.20 · Cited by 75
Treating the metabolic syndrome
Bianchi, C., Penno, G., Romero, F., Prato, S. D., & Miccoli, R. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.3.491 · Cited by 75
Risk of Cancer in Diabetes: The Effect of Metformin
Malek, M., Aghili, R., Emami, Z., & Khamseh, M. E. (2013) · ISRN Endocrinology · doi:10.1155/2013/636927 · Cited by 73
An Update on the Pharmacogenomics of Metformin: Progress, Problems and Potential
Todd, J. N., & Florez, J. C. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.21 · Cited by 72
Campagnoli, C., Pasanisi, P., Abbà, C., Ambroggio, S., Biglia, N., Brucato, T., Colombero, R., Danese, S., Donadio, M., Venturelli, E., et al. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.03.004 · Cited by 67
Site-specific uncoupling and inhibition of oxidative phosphorylation by biguanides. II
Schäfer, G. (1969) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(69)90077-2 · Cited by 61
Zhang, Y., Storr, S. J., Johnson, K., Green, A. R., Rakha, E. A., Ellis, I. O., Morgan, D. A. L., & Martin, S. G. (2014) · Oncotarget · doi:10.18632/oncotarget.2683 · Cited by 59
Journal of Bioequivalence & Bioavailability
(2018) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb · Cited by 54
Contributions of AMPK and p53 dependent signaling to radiation response in the presence of metformin
Muaddi, H., Chowdhury, S., Vellanki, R. N., Zamiara, P., & Koritzinsky, M. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.014 · Cited by 52
Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer
Oh, B. Y., Park, Y. A., Huh, J. W., Cho, Y. B., Yun, S. H., Lee, W. Y., Park, H. C., Choi, D. H., Park, Y. S., & Kim, H. C. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2148-x · Cited by 52
Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells.
Aldea, M. D., Petrushev, B., Şoriţău, O., Tomuleasa, C., Berindan‐Neagoe, I., Filip, G. A., Cherecheș, G., Cenariu, M., Craciun, L., Tatomir, C. B., et al. (2014) · PubMed · Cited by 51
Metformin and improved treatment outcomes in radiation therapy – A review
Samsuri, N. A. B., Leech, M., & Marignol, L. H. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.03.005 · Cited by 48
Metformin Sensitizes Prostate Cancer Cells to Radiation Through EGFR/p-DNA-PKCS In Vitro and In Vivo
Zhang, T., Zhang, L., Zhang, T., Fan, J., Wu, K., Guan, Z., Wang, X., Li, L., Hsieh, J. T., He, D., et al. (2014) · Radiation Research · doi:10.1667/rr13561.1 · Cited by 47
Low and high linear energy transfer radiation sensitization of HCC cells by metformin
Kim, E. H., Kim, M.-S., Cho, C.-K., Jung, W., Jeong, Y. K., & Jeong, J.-H. (2013) · Journal of Radiation Research · doi:10.1093/jrr/rrt131 · Cited by 45
Rieken, M., Kluth, L. A., Xylinas, E. N., Fajković, H., Becker, A., Karakiewicz, P. I., Herman, M. P., Lotan, Y., Seitz, C., Schramek, P., et al. (2013) · World Journal of Urology · doi:10.1007/s00345-013-1171-7 · Cited by 43
More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin
Berstein, L. M., Boyarkina, M. P., Tsyrlina, E. V., Turkevich, E. A., & Семиглазов, В. Ф. (2010) · Medical Oncology · doi:10.1007/s12032-010-9572-6 · Cited by 41
Choi, M., Jin, Q., Jin, H., Shim, C., Cho, D., Shin, J., & Song, I. (2007) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.576 · Cited by 36
Papaconstantinou, J., & Hsieh, C.-C. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13324 · Cited by 34
Use of Metformin in Diseases of Aging
Miles, J. M., Rule, A. D., & Borlaug, B. A. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0490-4 · Cited by 33
Ghatak, S. B., Dhamecha, P. S., Bhadada, S. V., & Panchal, S. J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.029 · Cited by 26
APC+/− alters colonic fibroblast proteome in FAP
Patel, B. B., Li, X., Dixon, M. P., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.241 · Cited by 19
Schatz, H. (2010) · Diabetologia · doi:10.1007/s00125-010-1844-3 · Cited by 5
THE EFFECTS OF METFORMIN ON PANCREATIC CANCER METABOLISM
Cantoria, M. J. (2014) · UA Campus Repository (The University of Arizona) · Cited by 2
Cited by
Hyperinsulinemia in Obesity, Inflammation, and Cancer
Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0250 · Cited by 305
Obesity, Diabetes, and Increased Cancer Progression
Kim, D.-S., & Scherer, P. E. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0077 · Cited by 302
Shiratori, R., Furuichi, K., Yamaguchi, M., Miyazaki, N., Aoki, H., Chibana, H., Ito, K., & Aoki, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-55296-3 · Cited by 291
The intersection of metformin and inflammation
Bharath, L. P., & Nikolajczyk, B. S. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00604.2020 · Cited by 134
Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
Belisario, D. C., Kopecka, J., Pasino, M., Akman, M., De Smaele, E., Donadelli, M., & Riganti, C. (2020) · Cells · doi:10.3390/cells9122598 · Cited by 133
Metadata
- Authors
- Saraei, P., Asadi, I., Kakar, M. A., & Moradi-Kor, N.
- Venue
- Cancer Management and Research
- Publisher
- Informa UK Limited
- Published
- 2019-04
- Volume
- Volume 11
- Pages
- 3295-3313
- ISSN
- 1179-1322 (ISSN-L)
- OpenAlex
- W2937270878
- Cited by
- 350
- References
- 105
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.